K

Kinarus AG

10 employees

Kinarus is focused on developing novel treatments for patients suffering from serious viral, respiratory, and ophthalmic diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Lung disease
Opthalmology
Covid-19
Regulatory
Inflammation
Clinical Development
Solid Dosage
Macular degeneration
Health Care
Kinase Drugs
Fibrosis
Antiviral
Medical
Mitogen Activated Protein Kinases
Biopharma
Life Science
Pharmaceuticals

Date founded

2017

Funding rounds raised

Total raised

$21M

from 2 investors over 2 rounds

K

Kinarus AG raised $1.7M on May 11, 2023

Investors: 上海超电文化传播有限公司

K

Kinarus AG raised $21M on August 22, 2022

Investors: Yorkville Advisors

FAQ